sur Data4Cure, Inc.
Data4Cure to Present Key Research at AACR 2024
Data4Cure, Inc., a leader in biomedical data analysis, has announced its participation in the upcoming 2024 American Association for Cancer Research (AACR) Annual Meeting with a research poster presentation. This event, set to take place from April 5-10 in San Diego, California, will feature the company's insights derived from its Biomedical Intelligence platform.
The presentation will focus on the Single-Cell Immune Checkpoint Inhibition Atlas (ICI Atlas), an extensive database containing over 4 million cells. This atlas, developed through deep learning, provides detailed information on the response and resistance to immunotherapies across nineteen different cancer types. Janusz Dutkowski, CEO and co-founder of Data4Cure, emphasized the significance of their findings in understanding the intricate cancer-immune interactions and the potential for developing new cancer therapies.
The presentation, titled "Interrogating the cancer-immunity cycle through the lens of a large-scale single-cell atlas," is scheduled for April 9, 2024. It aims to spark further partnerships and progression in cancer research by sharing groundbreaking data and methodologies.
R. H.Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Data4Cure, Inc.